GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (HAM:SYAB) » Definitions » Total Stockholders Equity

Synlab AG (HAM:SYAB) Total Stockholders Equity : €2,372 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Synlab AG Total Stockholders Equity?

Synlab AG's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €2,372 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Synlab AG's Book Value per Share for the quarter that ended in Mar. 2024 was €10.79. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Synlab AG's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.65.


Synlab AG Total Stockholders Equity Historical Data

The historical data trend for Synlab AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG Total Stockholders Equity Chart

Synlab AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
1,205.64 2,256.88 2,333.17 2,340.40

Synlab AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,355.68 2,306.44 2,418.91 2,340.40 2,371.92

Synlab AG  (HAM:SYAB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Synlab AG's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Synlab AG's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synlab AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Synlab AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Synlab AG (HAM:SYAB) Business Description

Traded in Other Exchanges
Address
Moosacher Strasse 88, Augsburg, BY, DEU, 80809
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (HAM:SYAB) Headlines

No Headlines